[Periodically occurring crystalluria and cerebral symptomatics in primidone therapy--a genetically dependent disorder of catabolism?].
D002648:Child; D003460:Crystallization; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006261:Headache / Q000139:chemically induced*; D006801:Humans; D011324:Primidone / Q000009:adverse effects* / Q000627:therapeutic use / Q000652:urine; D013064:Speech Disorders / Q000139:chemically induced*; D013997:Time Factors; D014717:Vertigo / Q000139:chemically induced*
D011324:Primidone
Phasenhaft auftretende Kristallurie und zerebrale Symptomatik unter Primidon-Therapie--eine genetisch bedingte Abbaustörung.